CG
DPLO

Cutler Group’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Cutler Group’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-18,700
Closed -$4K – 5026
2019
Q4 		$4K Sell
18,700
-5,000
-21% -$23.5K ﹤0.01% 3217
2019
Q3 		$4K Buy
23,700
+13,700
+137% +$76.7K ﹤0.01% 3246
2019
Q2 		$2K Buy
10,000
+700
+8% +$3.72K ﹤0.01% 3736
2019
Q1 		$2K Buy
+9,300
New +$96K ﹤0.01% 3551
2018
Q2 		– Sell
-10,900
Closed -$18K – 5230
2018
Q1 		$18K Buy
10,900
+5,100
+88% +$119K ﹤0.01% 2386
2017
Q4 		$21K Sell
5,800
-1,600
-22% -$31.5K ﹤0.01% 2535
2017
Q3 		$16K Buy
+7,400
New +$125K ﹤0.01% 3380
2017
Q2 		– Sell
-2,600
Closed -$2K – 7466
2017
Q1 		$2K Sell
2,600
-2,300
-47% -$33.2K ﹤0.01% 5661
2016
Q4 		$3K Sell
4,900
-3,000
-38% -$55.9K ﹤0.01% 5468
2016
Q3 		$2K Buy
7,900
+1,100
+16% +$36.9K ﹤0.01% 5906
2016
Q2 		$58K Sell
6,800
-9,400
-58% -$295K ﹤0.01% 2213
2016
Q1 		$46K Buy
16,200
+13,500
+500% +$398K ﹤0.01% 2428
2015
Q4 		$2K Buy
+2,700
New +$84.2K ﹤0.01% 5731

Other funds holding DPLO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Cutler Group's DPLO Position: Q1 2020 in Review

Cutler Group sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 300 shares — an estimated $1K sold.

Cutler Group first reported a position in DPLO in Q4 2015 and held it in 9 quarters. The position peaked at $283K in Q4 2016. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

  • Cutler Group reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
  • Cutler Group sold 300 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $1K.
  • Cutler Group first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2015 and held it in 9 quarters.
  • Cutler Group's DIPLOMAT PHARMACY, INC. position peaked at $283K in Q4 2016.
  • 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Cutler Group's 13F filing for Q1 2020, filed 7 May 2020.